However, the use of CBZ is limited due to the effects of drug–drug interaction involving the cytochrome p450; hence, the use of CBZ decreases the PRL level, in turn decreasing the prevalence of depression, while the use of LEV increases the PRL level. The gene discussed is PRL; the disease is depressive disorder.